Types of Prostate Biopsy: Which One Is Right for You?
Understand TRUS, transperineal, MRI-fusion, and saturation prostate biopsies. Learn how urologists s
Can you control your prostate cancer risk? While you cannot control all risk factors—age, family history, and genetics play significant roles—specific lifestyle modifications and screening protocols can reduce your risk and enable earlier detection when treatment outcomes may be more favourable.
Your prostate gland sits below your bladder and produces seminal fluid. After age 50, cellular changes become more common, making regular monitoring important. Men with first-degree relatives (father, brother) who had prostate cancer face an increased risk compared to those without a family history.
Age remains a significant predictor of prostate cancer. The disease rarely appears before age 40, but incidence increases after 50. By age 60, cellular abnormalities are detectable in many men, though not all progress to clinical cancer.
Family history creates measurable risk elevation. If your father or brother developed prostate cancer before age 60, your risk increases. Multiple affected relatives further increase your risk, warranting earlier and more frequent discussions with your urologist about screening.
Genetic mutations in BRCA1 and BRCA2 genes—typically associated with breast and ovarian cancer—also increase prostate cancer risk. Men carrying these mutations may develop more aggressive disease at younger ages. Genetic counselling becomes relevant when multiple family members have had breast, ovarian, or prostate cancer.
Cruciferous vegetables—broccoli, cauliflower, cabbage, and Brussels sprouts—contain sulforaphane and indole-3-carbinol, compounds that support healthy cell division. Consuming these vegetables four to five times weekly provides consistent exposure to these protective compounds.
Tomatoes deliver lycopene, a carotenoid that accumulates in prostate tissue. Cooked tomato products—sauces, pastes, and soups—concentrate lycopene and improve absorption compared to raw tomatoes. Include tomato-based dishes three to four times weekly.
Soy products contain isoflavones that may influence hormone metabolism. Tofu, tempeh, and edamame provide these compounds in whole food form. Two to three servings weekly offer a reasonable intake without excessive consumption.
Omega-3 fatty acids from fish oppose inflammatory processes linked to cancer development. Salmon, mackerel, and sardines provide EPA and DHA, the most bioactive omega-3 forms. Two servings of fatty fish per week provide adequate omega-3 intake.
Limit saturated fats from red meat and full-fat dairy products. High saturated fat intake may be associated with increased prostate cancer risk. When consuming red meat, choose lean cuts and limit portions to the size of your palm.
Avoid trans fats entirely. These artificial fats appear in some processed foods and commercial baked goods. Check ingredient lists for “partially hydrogenated oils” and select products without these additives.
Excessive calcium intake from supplements may increase risk. Most men can meet calcium needs through dietary sources—dairy, leafy greens, fortified foods—without supplementation. A healthcare professional can provide guidance on calcium supplements if you’re taking them for bone health.
Limit alcohol consumption. Heavy drinking may be associated with increased prostate cancer risk. If you drink, restrict intake to no more than two standard drinks daily.
Regular exercise influences hormone levels, reduces inflammation, and supports immune function—all factors relevant to cancer prevention.
Moderate-intensity exercise for 150 minutes weekly provides baseline protection. Brisk walking, swimming, cycling, or recreational sports qualify. Divide this into 30-minute sessions five days a week for consistency.
Vigorous exercise—running, competitive sports, high-intensity interval training—may offer additional benefits. Men who engage in vigorous activity may show lower prostate cancer risk. Three 25-minute vigorous sessions weekly meet this threshold.
Strength training twice weekly supports healthy body composition. Maintaining lean muscle mass helps regulate insulin and sex hormones. Focus on major muscle groups—legs, back, chest, shoulders—using resistance that allows 8-12 repetitions per set.
Avoid prolonged sitting. Men with sedentary jobs should stand and move for 5 minutes every hour. Physical activity throughout the day contributes to overall metabolic health beyond dedicated exercise sessions.
Excess body fat produces inflammatory compounds and alters hormone metabolism. Obesity can be a risk factor for aggressive prostate cancer and may affect treatment outcomes.
Track your body mass index (BMI). Values between 18.5 and 24.9 indicate a healthy weight for most men. Calculate BMI by dividing your weight in kilograms by your height in meters squared, or use online calculators.
Waist circumference provides additional information about metabolic risk. Measure around your abdomen at navel level. Values above 90 cm (35 inches) indicate increased metabolic risk that may influence cancer development.
Consider sustainable dietary patterns rather than restrictive diets. Mediterranean-style eating—emphasising vegetables, fruits, whole grains, fish, and olive oil—supports a healthy weight while providing protective nutrients.
Prostate-specific antigen (PSA) testing measures a protein produced by prostate cells. Elevated levels may indicate cancer, but also occur with benign prostate enlargement and prostatitis.
Screening discussions should begin at age 50 for men at average risk. A healthcare professional will explain the benefits and limitations of PSA testing, helping you decide whether screening aligns with your preferences.
Men at elevated risk—those with a family history—should discuss screening at age 40 to 45. Earlier baseline testing establishes normal PSA levels and enables monitoring of changes over time.
PSA levels below 1.0 ng/mL generally warrant testing every 2-4 years. Values between 1.0 and 2.5 ng/mL may require annual monitoring. Levels above 2.5 ng/mL need thorough evaluation, though this threshold varies by age.
PSA velocity—rate of increase over time—sometimes reveals cancer earlier than absolute levels. Rising PSA values of 0.75 ng/mL or more annually warrant investigation even when levels remain within normal ranges.
During DRE, a urologist palpates the prostate through the rectal wall, checking for hard nodules, asymmetry, or irregular texture. The examination takes less than one minute and provides information unavailable through PSA testing alone.
Some prostate cancers produce minimal PSA elevation but create palpable abnormalities. Combining PSA testing with DRE may increase the sensitivity of detection.
The examination occurs during routine urology visits. A urologist assesses the size, shape, and consistency of the prostate, noting any suspicious areas that require further evaluation with imaging or biopsy.
Men with concerning PSA levels or abnormal DRE findings may need a multiparametric MRI. This imaging technique identifies suspicious areas within the prostate, guiding targeted biopsies toward regions most likely to contain cancer.
Prostate biopsy remains the only definitive cancer diagnosis method. During the procedure, a urologist obtains tissue samples from various regions of the prostate. Pathologists examine these samples for cancer cells and grade any tumours found.
Biomarker tests help distinguish aggressive cancers from slow-growing tumours. These tests analyse blood or urine samples, providing additional information when PSA results fall in intermediate ranges.
Tobacco use increases the risk of aggressive prostate cancer and worse treatment outcomes. Men who smoke show higher rates of disease progression and cancer-related mortality compared to non-smokers.
Nicotine replacement therapy—patches, gum, lozenges—can help with quit attempts. These products deliver controlled nicotine doses while eliminating toxic combustion products from cigarettes.
Prescription medications like varenicline or bupropion may support cessation efforts. These drugs reduce cravings and withdrawal symptoms, making the quitting process more manageable.
Behavioural support through counselling or quit-smoking programs provides additional assistance. Many men benefit when combining medication, nicotine replacement, and professional guidance.
Chronic inflammation creates an environment where cancer cells develop more readily. Several lifestyle factors influence inflammatory status.
Sleep duration affects inflammatory markers. Most men need 7-9 hours nightly. Consistent sleep schedules—going to bed and waking at similar times daily—support healthy sleep architecture.
These stress management techniques reduce cortisol and inflammatory cytokines.
Dental health influences systemic inflammation. Periodontal disease releases inflammatory compounds into your bloodstream. Brush twice daily, floss regularly, and see your dentist for professional cleanings every six months.
Some medications influence prostate cancer risk, though none are currently approved for cancer prevention.
5-alpha-reductase inhibitors—finasteride and dutasteride—reduce prostate cancer incidence in clinical trials but may increase rates of high-grade tumours. These medications treat benign prostate enlargement and male pattern baldness. Discuss risks and benefits with your healthcare professional if you’re taking these drugs for other reasons.
Aspirin use shows mixed results in prostate cancer prevention studies. Some research suggests protective effects, though aspirin carries a risk of bleeding. Aspirin should be taken for cardiovascular indications as recommended by a healthcare professional.
Vitamin E and selenium supplements do not prevent prostate cancer and may increase risk in some men. The SELECT trial found higher prostate cancer rates among men taking these supplements. Avoid megadose supplementation unless treating a documented deficiency.
Combine multiple protective factors for benefit. Men who maintain a healthy weight, exercise regularly, eat plant-rich diets, and undergo appropriate screening may have improved health outcomes.
Track your health metrics—weight, waist circumference, exercise frequency, and dietary patterns. Monitoring these factors helps you identify trends and adjust behaviours before problems develop.
Schedule regular check-ups with your primary care doctor—many protective strategies—weight management, exercise, dietary changes—support overall health beyond cancer prevention. Coordinate care between your primary doctor and urologist for comprehensive health maintenance.
The most effective prevention approach combines regular PSA screening after age 50 (or 40-45 with family history), a Mediterranean-style diet emphasising cruciferous vegetables and tomatoes, and 150 minutes of weekly exercise. Men with elevated PSA levels or family history require individualised screening schedules with their urologist.
If you are experiencing difficulty urinating, blood in urine, or have a family history of prostate cancer, consult with Dr Tan Teck Wei to establish your personalised screening protocol.
MBBS (S’pore)
DFD (CAW)
MRCS (Edin)
MMed (Surgery)
FAMS (Urology)
Dr Tan Teck Wei is a Senior Consultant Urologist in Singapore who specialises in the management of complex urological cancers, including those affecting the kidneys, prostate, and bladder.
He is fellowship-trained in open, laparoscopic and robotic surgery. He also specialises in the management of other urological conditions including:
To date, Dr Tan Teck Wei has been involved in more than 500 robot-assisted surgeries, building up his volume of cases from his fellowship training days and cementing his expertise in robotic surgery.
Dr Tan Teck Wei believes in the holistic management of his patients, and seeks to journey with them from diagnosis to cure. Dr Tan is effectively bilingual in English and Mandarin, making him a popular choice with the young and old, as well as international patients.
Dr Tan Teck Wei possesses a wealth of specialist experience in the field of Urology. He has previously held positions as a Consultant Urologist and Director of Genitourinary Oncology at Tan Tock Seng Hospital.
Dr Tan’s expertise in conducting MRI-targeted Prostate Biopsies led to his advisory role with the Ministry of Health’s Agency for Care Effectiveness. Furthermore, he has served as an Adjunct Assistant Professor and Clinical Teacher at the National University of Singapore (NUS) Yong Loo Lin School of Medicine and the Nanyang Technological University-Imperial College London’s Lee Kong Chian School of Medicine respectively.
He has actively participated in humanitarian initiatives as a member of the Singapore Navy surgical team, collaborating with the Indonesian Navy to provide healthcare services to the communities in Padang and Ambon. It is his passion to improve the standards of healthcare to patients both in Singapore and overseas.
For urgent or same day appointment requests,
please call our hotline at +65 6518 3622.